Literature DB >> 29248482

Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice.

Hao Wang1, Fang Chen2, Yi-Feng Du3, Yan Long2, Miranda N Reed3, Mei Hu2, Vishnu Suppiramaniam3, Hao Hong4, Su-Su Tang5.   

Abstract

AIMS: To investigate restorative effects of the receptor for advanced glycation end products (RAGE)-specific inhibitor FPS-ZM1 on abnormal amyloid β (Aβ) influx across the blood brain-barrier (BBB) and cognitive deficits in db/db mice.
METHODS: Aβ influx across the BBB was determined by intra-arterial infusion of 125I-Aβ1-40. Receptor for advanced glycation end products (RAGE), Aβ, NF-κB p65, caspase-3, Bax, Bcl-2, PSD-95 and synaptophysin were assayed by Western blot, immunohistochemistry or RT-PCR. Apoptosis was quantified by TUNEL assay. In vivo hippocampal long term potentiation (LTP) recording, Golgi Staining, Morris water maze (MWM) task and Y-maze test were performed.
RESULTS: FPS-ZM1 (1.0 mg/kg i.p.) inhibited Aβ influx across the BBB and expression of RAGE participating in Aβ influx, consequently decreased hippocampal Aβ1-40 and Aβ1-42 in db/db mice. After FPS-ZM1 treatment, NF-κB signaling was inhibited, and neuronal apoptosis was reduced, which revealed by less TUNEL + cells, reduced caspase-3 activity and higher ratio of Bcl-2/Bax. In addition, FPS-ZM1 improved hippocampal plasticity evidenced by enhanced in vivo LTP and the restoration of spine deficit and increased PSD-95 expression in hippocampal neuron. Further studies found that FPS-ZM1 treatment alleviated cognitive deficits shown by better performance in behavioral tests, without significant metabolic effects on blood glucose, insulin and cerebral AGEs.
CONCLUSION: Downregulation of abnormal Aβ influx across the BBB by FPS-ZM1 at higher dosage contributes to reduced neuronal apoptosis, improved hippocampal plasticity and cognitive impairment in db/db mice.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amyloid-β; Blood-brain barrier; Cognitive deficits; Receptor for advanced glycation end products; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2017        PMID: 29248482     DOI: 10.1016/j.neuropharm.2017.12.026

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  17 in total

1.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

2.  Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro.

Authors:  Elvis Cuevas; Hector Rosas-Hernandez; Susan M Burks; Manuel A Ramirez-Lee; Aida Guzman; Syed Z Imam; Syed F Ali; Sumit Sarkar
Journal:  Metab Brain Dis       Date:  2019-07-02       Impact factor: 3.584

3.  Liraglutide Alleviates Cognitive Deficit in db/db Mice: Involvement in Oxidative Stress, Iron Overload, and Ferroptosis.

Authors:  Ji-Ren An; Jia-Nan Su; Gui-Yan Sun; Qing-Feng Wang; Ya-Dong Fan; Nan Jiang; Yu-Feng Yang; Yan Shi
Journal:  Neurochem Res       Date:  2021-09-04       Impact factor: 3.996

Review 4.  Cognitive Deficits in Type-1 Diabetes: Aspects of Glucose, Cerebrovascular and Amyloid Involvement.

Authors:  Justin Pickering; Rachel Wong; Hani Al-Salami; Virginie Lam; Ryu Takechi
Journal:  Pharm Res       Date:  2021-09-03       Impact factor: 4.200

Review 5.  The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer's disease.

Authors:  Yan-Li Zhang; Juan Wang; Zhi-Na Zhang; Qiang Su; Jun-Hong Guo
Journal:  Neural Regen Res       Date:  2022-11       Impact factor: 6.058

6.  Single-Cell Sequencing Analysis of the db/db Mouse Hippocampus Reveals Cell-Type-Specific Insights Into the Pathobiology of Diabetes-Associated Cognitive Dysfunction.

Authors:  Shizhan Ma; Wenkai Bi; Xueying Liu; Shangbin Li; Yaxin Qiu; Chengcheng Huang; Renjun Lv; Qingqing Yin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-01       Impact factor: 6.055

7.  Lowered levels of nicotinic acetylcholine receptors and elevated apoptosis in the hippocampus of brains from patients with type 2 diabetes mellitus and db/db mice.

Authors:  Yi Xu; Kun Cao; Bing Guo; Jie Xiang; Yang-Ting Dong; Xiao-Lan Qi; Wen-Feng Yu; Yan Xiao; Zhi-Zhong Guan
Journal:  Aging (Albany NY)       Date:  2020-07-23       Impact factor: 5.682

8.  Receptor for Advanced Glycation End Products (RAGE) Mediates Cognitive Impairment Triggered by Pneumococcal Meningitis.

Authors:  Vijayasree V Giridharan; Jaqueline S Generoso; Allan Collodel; Diogo Dominguini; Cristiano Julio Faller; Flavio Tardin; Gursimrat S Bhatti; Fabricia Petronilho; Felipe Dal-Pizzol; Tatiana Barichello
Journal:  Neurotherapeutics       Date:  2021-01       Impact factor: 7.620

9.  HMGB1-RAGE Pathway Contributes to the Abnormal Migration of Endogenous Subventricular Zone Neural Progenitors in an Experimental Model of Focal Microgyria.

Authors:  Yi-Wen Mei; Tian-Lan Huang; Xin Chen; Si-Xun Yu; Jie Li; Zhi Zhang; Yang He; Da-Qing Guo; Hai-Feng Shu
Journal:  J Mol Neurosci       Date:  2021-08-09       Impact factor: 3.444

10.  High glucose-induced complement component 3 up-regulation via RAGE-p38MAPK-NF-κB signalling in astrocytes: In vivo and in vitro studies.

Authors:  Yuxing Zhao; Cheng Luo; Jinliang Chen; Yue Sun; Die Pu; Ankang Lv; Shiyu Zhu; Jing Wu; Meili Wang; Jing Zhou; Zhiyin Liao; Kexiang Zhao; Qian Xiao
Journal:  J Cell Mol Med       Date:  2018-09-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.